EUVIMEDEUVIMED entdecken
Crossref

EGFR-Degrading PROTACs and Calcium Peroxide Co-loaded Liposomes: Enabling EGFR Degradation and Hypoxia Alleviation as Dual Safeguards for NSCLC Therapy

Lei Fang iD, Yue Wu iD, Jiarui Wang, Yu Wu iD, Junhui Ma iD, Xiuju Li, Wei Deng, Haixia Ma, Yulong Li, Guangya Xiang, Xiang Ma iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c10600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Lei Fang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Liposomes, Lung Neoplasms, Peroxides. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Guizhou Science and Technology Department, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis targeting chimeras (PROTACs) have been utilized to overcome drug resistance by degrading mutant EGFR in non-small cell lung cancer (NSCLC) therapy. However, their therapeutic efficacy is often compromised by the complex tumor microenvironment, which can lead to the reduced sensitivity of lung cancer cells to PROTACs. In this study, oxygen supplier (CaO2) and PROTAC co-loaded liposomes (LCP) are developed for simultaneously promoting EGFR degradation and hypoxic microenvironment alleviation. Calcium peroxide (CaO2) can release oxygen to modulate the hypoxic microenvironment, thereby reducing HIF-1α expression and enhancing the sensitivity of lung cancer cells. Compared with PROTACs administered alone, LCP exhibited enhanced tumor cell killing effect, improved protein degradation capacity, and superior tumor growth inhibition in NSCLC animal models. Mechanistic analysis reveals that LCP modulates hypoxia-associated proteins, including FGFR1, ERK, and TGF-α, contributing to the enhanced therapeutic efficacy. The LCP developed herein offers a strategy for enhancing NSCLC therapy by remodeling the hypoxic tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLiposomesLung NeoplasmsPeroxidesAntineoplastic AgentsHumansProteolysis Targeting ChimeraErbB ReceptorsAnimalsMiceTumor MicroenvironmentCell Line, TumorCell HypoxiaHypoxia-Inducible Factor 1, alpha SubunitProteolysis

Stichwörter der Autor:innen

EGFR degradationPROTACscalcium peroxidehypoxianon-small cell lung cancer

Substanzen

Proteolysis Targeting ChimeraLiposomesErbB Receptorscalcium peroxidePeroxidesEGFR protein, humanAntineoplastic AgentsHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.
  • Department of Pharmacy, Tongren Polytechnic College, Tongren554300, China.
  • Institute of The Higher Education Edible and Medicinal Fungi Engineering Research Center, Tongren554300, China.

ORCID-Profile: Lei Fang, Yue Wu, Yu Wu, Junhui Ma, Xiang Ma

Förderung

  • Guizhou Science and Technology Department
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Fang, L., Wu, Y., Wang, J., Wu, Y., Ma, J., Li, X., Deng, W., Ma, H., Li, Y., Xiang, G., & Ma, X. (2026). EGFR-Degrading PROTACs and Calcium Peroxide Co-loaded Liposomes: Enabling EGFR Degradation and Hypoxia Alleviation as Dual Safeguards for NSCLC Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c10600

Vancouver

Fang L, Wu Y, Wang J, Wu Y, Ma J, Li X, et al. EGFR-Degrading PROTACs and Calcium Peroxide Co-loaded Liposomes: Enabling EGFR Degradation and Hypoxia Alleviation as Dual Safeguards for NSCLC Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c10600

BibTeX
@article{Fang2026,
  author = {Fang, Lei and Wu, Yue and Wang, Jiarui and Wu, Yu and Ma, Junhui and Li, Xiuju and Deng, Wei and Ma, Haixia and Li, Yulong and Xiang, Guangya and Ma, Xiang},
  title = {EGFR-Degrading PROTACs and Calcium Peroxide Co-loaded Liposomes: Enabling EGFR Degradation and Hypoxia Alleviation as Dual Safeguards for NSCLC Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c10600}
}
Kostenlos starten →